Biospecific desorption microflow systems and methods for studying biospecific interactions and their modulators

• US 20040005582A1
• Filed: 12/19/2002
• Published: 01/08/2004
• Est. Priority Date: 08/10/2000
• Status: Abandoned Application

• Current Assignee: Nano Dynamics Incorporated
• Original Assignee: Nano Dynamics Incorporated
• Inventors: Shipwash, Edward
• Application Number:
  US10/327,531
• Publication Number:
  US 20040005582A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: B01L 2300/0816 Cards, e.g. flat sample carriers usually with flow in two horizontal directions
• CPC Class Codes: B01L 2300/0867 Multiple inlets and one sample wells, e.g. mixing, dilution
• CPC Class Codes: B01L 2300/0877 Flow chambers
• CPC Class Codes: B01L 2400/0409 centrifugal forces
• CPC Class Codes: B01L 2400/0415 electrical forces, e.g. electrokinetic
• CPC Class Codes: B01L 2400/0487 fluid pressure, pneumatics
• CPC Class Codes: B01L 3/5027 by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip B01L3/5023 takes precedence; micromixers B01F33/30; microreactors for synthesis B01J19/0093; microcapillary devices in general B81B1/00
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing

Abstract

Biospecific desorption microflow systems and methods employing immobilized prebound members of a binding pair are disclosed are used in detecting analytes in samples, identifying binding sites and studying biospecific interactions and their inhibitors on intact cells, cell membranes, cell organelles, cell fragments, proteins, and other biopolymers. The microflow reaction channel is in fluid connection with one or more reservoirs each having a means for transporting fluids or sample to a microflow channel having a prebound binding pair. The biospecifically desorbed labeled molecules may be continuously detected and quantitated on-line. Apparent dissociation constants and 1C50 values (for inhibitors) may be computed automatically. Fluorescent, luminescent, or electrogenic labels may be used to provide continuous flow microsystems having subpicomole sensitivities. Using microfluidic arrays, a single sample may be analyzed for the presence of multiple functional binding sites simultaneously. The method finds use as a universal technique for mapping the surfaces of proteins (epitope mapping) and other biopolymers for functional binding elements. The method is especially suitable for the functional analysis of the multitude of consensus sequences that are emerging from genome programs (for verification that a binding site predicted from a genome sequence is indeed functional) and for studying biospecific interactions that occur in the extracellular environment e.g. blood coagulation/fibrinolysis, inflammation, cell migration, bone biology, tissue and organ formation and regrowth. The method is well suited for studying biospecific interaction in an automated and highly controlled manner and for rapidly screening drug candidates for blocking these interactions.

Claims

1. A microfluidic biospecific desorption assay method for characterizing the binding site of a protein, said method comprising:

(1) establishing a buffer flow through a microchannel in fluidic contact with an immobilized binding complex comprising a first immobilized binding pair member and a second labeled binding pair member;

wherein one of the first or second members is the protein or a fragment of the protein; and

wherein the protein or protein fragment is bound to the other binding pair member via the binding site;

(2) introducing a polypeptide into the buffer flow;

wherein the polypeptide has an amino acid subsequence of the protein;

(3) detecting the desorption of the label following introduction of the polypeptide; and

repeating steps (2) and (3) for each of a plurality of polypeptides of differing amino acid sequences, wherein at least one of the polypeptides comprises the binding site;

whereby the polypeptide comprising the binding site is identified and the binding site is thereby localized to a portion of the protein having the amino acid sequence of the polypeptide comprising the binding site.

2. The method of claim 1, wherein the protein is an antigen, the binding member complex comprises the antigen and an antibody directed toward the antigen;

and the binding site is an epitope of the antigen.

3. The method of claim 1, wherein the binding pair complex comprises a polynucleotide.

4. The method of claim 3, wherein the polynucleotide is DNA.

5. The method of claim 3, wherein the polynucleotide is RNA.

6. The method of claim 1, wherein the binding pair complex comprises an oligosaccharide.

7. The method of claim 1, wherein the protein is labeled.

8. The method of claim 1, wherein the protein is immobilized.

9. The method of claim 1, wherein the immobilized binding pair member is immobilized by covalent or noncovalent bonds.

10. The method of claim 1, wherein the polypeptide is from 5 to 20 amino acids in length.

11. The method of claim 1, wherein the polypeptide is from 20 to 100 amino acids in length.

12. The method of claim 1, wherein the polypeptide is from 50 to 250 amino acids in length.

13. The method of claim 1, wherein the polypeptide is a fragment of the protein.

14. The method of claim 1, wherein the label is fluorescent, colored, radioactive, enzymatic, or chemiluminescent.

15. The method of claim 1, wherein said detection system comprises a biosensor selected from the group consisting of a piezoelectric crystal, a surface plasmon resonance system, an acoustic wave sensor device, a fluorescence detector or a proximity scintillation surface.

16. An integrated microfluidic system for performing competitive displacement studies of a protein binding site, comprising:

(a) a plurality of addressed reaction microchannels, wherein each microchannel has a first binding pair member immobilized therein and an inlet for receiving a sample and a discharge outlet, and wherein a second labeled binding pair member is reversibly bound to the first member to form an immobilized complex therewith, wherein one of the first and second members is the protein and wherein the first and second members are bound via the binding site;

(b) a plurality of sample polypeptides, wherein each polypeptide has an amino acid subsequence of the protein, and wherein at least one polypeptide of the plurality comprises the binding site;

(c) a means for separately inputting at least one of each sample polypeptide into the sample inlet of at least one of each reaction microchannel;

(d) a means for inputting fluid from a buffer reservoir into each microchannel;

(e) a detection system for each reaction microchannel, said detection system detecting a product of the dissociation of the complex;

(f) a waste reservoir in fluid connection with the discharge outlet.

17. The system of claim 16, wherein the label is fluorescent, colored, radioactive, enzymatic, or chemiluminescent.

18. The system of claim 16, wherein said detection system comprises a biosensor selected from the group consisting of a piezoelectric crystal, a surface plasmon resonance system, an acoustic wave sensor device, a fluorescence detector or a proximity scintillation surface.

19. The system of claim 16, wherein the polypeptide is from 20-200 amino acids in length.

20. The system of claim 16, wherein the polypeptide is from 10 to 100 amino acids in length.

21. The system of claim 16, wherein the polypeptide is from 5 to 50 amino acids in length.

22. A microfluidic biospecific desorption assay method for characterizing the binding motifs of proteins, said method comprising:

(1) establishing a buffer flow in a microchannel in fluidic contact with an immobilized binding complex comprising a first immobilized binding pair member and a second labeled binding pair member;

wherein at least one of the first or second members is a protein of known amino acid sequence having the binding motif and wherein the protein is bound to the other member of the binding pair via the binding motif;

(2) introducing a fragment of the protein into the microchannel buffer flow;

wherein the fragment is of known amino acid sequence; and

wherein the fragment comprises a minority portion of the protein; and

(3) detecting the desorption of the labeled member;

whereby the binding motif of the protein is located to within or without the portion.

23. The method of claim 22, wherein steps (2) and (3) are repeated for each of a plurality of different fragments of the protein, wherein at least one of the plurality of fragments comprises the binding motif;

whereby the desorption of the labeled member upon contact with the fragment comprising the binding motif is detected and the binding motif of the first biopolymer is localized to a region of the protein corresponding to the known sequence of the fragment comprising the binding motif.

24. The method of claim 22, wherein the protein is an antigen, and the binding member complex comprises the antigen and an antibody directed toward the antigen.

25. An integrated microfluidic amino acid analysis system for performing competitive displacement studies, comprising:

(a) a plurality of reaction microchannels, wherein each microchannel has a first binding pair member immobilized therein and an inlet for receiving a sample and a discharge outlet,

(b) a second labeled binding pair member reversibly bound to the first and forming an immobilized complex;

(c) at least one reservoir for input to said microchannels, wherein said reservoir is in fluid connection to at least one microchannel;

(d) a means for inputting fluid from the reservoir to each microchannel;

(e) a means for inputting sample into each microchannel;

(f) a detection system for each reaction microchannel, said detection system detecting a product of the dissociation of the complex;

(g) a waste reservoir in fluid connection with said discharge outlet.

26. The system of claim 25, wherein the label is fluorescent, colored, radioactive, enzymatic, or chemiluminescent.

27. The system of claim 25, wherein said detection system comprises a biosensor selected from the group consisting of a piezoelectric crystal, a surface plasmon resonance system, an acoustic wave sensor device, a fluorescence detector or a proximity scintillation surface.